Position on LGBTQ rights
The AMA supports allowing transgender and intersex athletes to compete in sports that align with their gender identity and believes that attempts to ban trans and intersex athletes from sports is discrimination and hurts the mental and physical health of trans people. Additionally, the AMA opposes sports eligibility criteria that would force trans and intersex athletes to alter their hormones to participate in sports and opposes hormonal guidelines to determine gender classification for sports eligibility as well as physician participation in confirming an athlete's gender to determine eligibility.
The AMA also supports allowing trans people to use single-sex facilities that align with their gender identity and opposes attempts to ban trans people from single-sex facilities that align with their gender identity.
The AMA supports public and private health insurance coverage for gender-affirming care and opposes insurance exclusion on such care.
In 2021, the AMA issued statements advocating strongly in favor of the use of puberty blockers for transgender youth, and against any legislation restricting such.
In 2023, members of the Endocrine Society submitted a resolution that advocated against legislation criminalizing access to gender-affirming healthcare and supported efforts to oppose discriminatory policies. This resolution led to the AMA's decision to strengthen its position on protecting gender-affirming care.
In 2025, the AMA rejected the Trump administration HHS gender dysphoria report, saying that its claims are "rooted in politics and partisanship, misrepresent the consensus of medical science, undermine the professionalism of physicians, and risk harming vulnerable young people and their families". The report was written in compliance with Executive Order 14187, which made it illegal for the federal government to advocate in favor of gender-affirming care under the age of 19. The report contradicted the consensus of the mainstream medical community, instead advocating for conversion therapy as the primary means of treatment for transgender youth.
On February 4, 2026, a day after the American Society of Plastic Surgeons (ASPS) heavily cited the Trump report to advocate against gender affirming surgeries under the age of 19, news outlets reported that the AMA had agreed with the ASPS. However, AMA's board released a statement claiming the media was misrepresenting what they had told them. The AMA board claimed that they never said they agreed with the ASPS statement nor had they changed their position on gender-affirming care. They said that they still support gender-affirming care as "medically necessary" and that their "recent response to questions about ASPS's position statement was intended to preserve—not diminish—access to gender-affirming care". Additionally, the AMA board said that they had sent letters to news outlets like the New York Times asking them to correct their stories which mischaracterized their statement.
On February 5, 2026, an AMA spokesperson reaffirmed the organization's support for puberty blockers for trans youth and said their position on puberty blockers had not changed, nor did they have any plans to change it.
The AMA continues to oppose restrictions on gender-affirming care for trans youth. On February 17, 2026, the AMA sent letters opposing two proposed CMS rules that would restrict doctors and hospitals from providing gender-affirming care to minors, saying the rules "interfere with the practice of medicine and undermine the physician-patient relationship" and requesting that the rules be withdrawn.
On February 23, 2026, 20 Republican state attorney generals, led by Alabama's Steve Marshall, sent a letter to the AMA threatening to investigate them under state consumer protection laws if they kept supporting puberty blockers and hormones for trans youth.
In March, it was revealed that representatives for the ASPS, the AMA and several other medical organizations had met with Dr. Mehmet Oz, a member of the Trump administration who vehemently opposes gender-affirming care prior to the release of their new statement. During the meeting, Dr. Oz attempted to pressure the organizations to abandon their support for gender-affirming care. The Society for Evidence-Based Gender Medicine (SEGM), an SPLC-designated hate group was also present at the meeting and Kathleen McDeavitt, one of the co-authors of the HHS report, also gave a presentation at the meeting. This led to speculation and accusations that the ASPS and AMA statements opposing surgeries for minors may have been influenced by the Trump administration, although the ASPS, for its part, denies this.